Attached files

file filename
8-K - CURRENT REPORT - Celularity Incea144415-8k_celularityinc.htm
EX-4.1 - SPECIMEN COMMON STOCK CERTIFICATE OF THE COMPANY - Celularity Incea144415ex4-1_celularity.htm
EX-3.2 - AMENDED AND RESTATED BYLAWS OF CELULARITY INC. - Celularity Incea144415ex3-2_celularity.htm
EX-99.2 - UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION AS OF AND FOR THE Y - Celularity Incea144415ex99-2_celularity.htm
EX-99.1 - PRESS RELEASE DATED JULY 16, 2021 - Celularity Incea144415ex99-1_celularity.htm
EX-10.3 - AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT - Celularity Incea144415ex10-3_celularity.htm
EX-4.2 - SPECIMEN WARRANT CERTIFICATE OF THE COMPANY - Celularity Incea144415ex4-2_celularity.htm
EX-10.4 - VESTING AGREEMENT DATED AS OF JULY 16, 2021 BY AND AMONG GX SPONSOR LLC, CELULAR - Celularity Incea144415ex10-4_celularity.htm
EX-16.1 - LETTER FROM MARCUM LLP - Celularity Incea144415ex16-1_celularity.htm
EX-10.15 - FORM OF DEFERRED COMPENSATION GRANT NOTICE - Celularity Incea144415ex10-15_celularity.htm
EX-3.1 - AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CELULARITY INC. - Celularity Incea144415ex3-1_celularity.htm
EX-21.1 10 ea144415ex21-1_celularity.htm LIST OF SUBSIDIARIES

Exhibit 21.1

 

List of Subsidiaries

 

Celularity LLC, a Delaware limited liability company

Anthrogenesis, LLC, a New Jersey limited liability company

Caricord Inc., a Delaware corporation